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Mammalian carboxylesterases (E.C. 3.1.1.1) are serine esterases constituting a family of isoenzymes that are implicated in several physiological processes. Multiple forms of carboxylesterase have been identified in mammalian tissues and some have been shown to differ in biochemical, immunological, and genetic properties [for review see (1) and references therein]. Carboxylesterase activity is widely distributed in mammalian tissues with the highest levels being present in liver microsomes (2) . The ability of carboxylesterases to hydrolyze various xenobiotoics and endogenous substrates such as esters, thioesters, or amide bonds indicate that the known functions of these enzymes are mainly for drug metabolism and detoxification of harmful chemicals (1) .
Some carboxylesterases have been found to preferentially hydrolyze lipids such as long-chain acyl-CoA (3), cholesteryl ester (4), and triacylglycerol 1 (TG) (5) . Some carboxylesterases are thought to participate in transport of fatty acids across the endoplasmic reticulum membrane or in maintenance of membrane structure.
In the liver, mobilization of stored TG to supply fatty acids for metabolic energy occurs via an initial hydrolysis of stored TG and subsequent re-synthesis of TG as a component of very low density lipoproteins (VLDL) [for review see (6) ]. Although the enzymes catalyzing de novo synthesis of TG are associated with endoplasmic reticulum membranes, approximately 70% of the TG that is secreted by hepatocytes in VLDL has been calculated to arise from a cytosolic storage pool whereas only 30% is derived from de novo TG synthesis (7, 8) . Hormone-sensitive lipase, while fundamental in adipose tissue lipid metabolism and overall energy homeostasis, is not expressed in liver in 4 sufficient quantities to account for the rate of lipolysis of stored TG and subsequent VLDL secretion (7).
Lehner and Verger (5) reported the purification of a member of the carboxylesterase family from porcine liver, microsomal triacylglycerol hydrolase (TGH), capable of hydrolyzing long-, medium-and short-chain TGs in vitro (5) . Further detailed characterization of TGH with respect to its intracellular location, developmental expression, and tissue and species specificity strongly supported a role for TGH in the lipolysis of cytoplasmic TG, some of which is used for assembly into VLDL (9) . Stable expression of rat TGH cDNA in McArdle RH7777 cells, a rat hepatoma cell line that lacks TGH and is defective in VLDL secretion, demonstrated unambiguously that TGH does indeed hydrolyze stored TG (10) .
In our previous studies we observed increased expression of rat TGH mRNA and protein in liver at the time of weaning, coincident with an enhanced ability to secrete VLDL (9) . The aim of the present study was to determine whether the increased expression of TGH seen at the time of weaning is linked to transcriptional regulation and to identify potential transcription factors and cis-acting DNA elements that might mediate the observed developmental expression of TGH in liver.
EXPERIMENTAL PROCEDURES
Isolation of Protein and RNA -Livers samples from mice of various ages were washed with ice-cold phosphate-buffered saline and homogenized using a Polytron homogenizer (Brinkman Instruments, Ontario, Canada) for 30 s at low speed in 250 mM sucrose, 25 mM Tris-HCl (pH 7.4), and 5 mM EDTA to yield 20% (w/v) crude extract.
Unbroken cells and cellular debris were removed by 10 min centrifugation at 500 x g.
Protein concentrations of total liver homogenates (supernatants) were determined by the micro BCA method (Pierce) using bovine serum albumin as a standard. For RNA isolation, livers were immediately frozen in liquid nitrogen prior to extraction of total RNA using Trizol reagent (Gibco BRL secondary antibodies used were goat anti-rabbit IgG, rabbit anti-goat IgG, or goat antimouse IgG (Pierce) and were detected using the enhanced chemiluminescence system (Amersham Pharmacia Biotech) according to the manufacturer's instructions. Where indicated, primary and secondary antibodies were stripped from the membrane by incubation with 100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl (pH 6.7) for 30 min at 50…C and the blot was re-probed with another antibody. The primary antibodies used were affinity purified anti-TGH polyclonal antibody (5), anti-actin monoclonal antibody (Sigma, clone no. AC74, cat. no. A 5316), and from Santa Cruz Biotech,
and anti-YY1 (sc-1703x,). In some cases, primary incubations with anti-Sp antibodies also contained competitive antigenic peptides to identify antigenically related proteins.
These peptides were SP1(PEP2)P (sc-59P), SP2(K-20)P (sc-643P) and SP3(D-20)P (sc-644P) from Santa Cruz Biotech.
Northern Blot Analysis --Equivalent amounts of total RNA (2.5 g) were electrophoresed in a 1.2% agarose/formaldehyde gel and transferred to HyBond-N+ membrane. TGH mRNA was detected by incubation of the membrane with a [ 8 (-rNTPs) were included to control for mRNAs synthesized by endogenous rNTPs in isolated nuclei.
Cloning of the Murine TGH Promoter and Plasmid Construction -Genomic sequences
containing the putative proximal murine TGH promoter were identified by Southern blot analysis of BAC clone 313P24 that contains the complete murine TGH gene (13) .
Briefly, BAC DNA was digested with EcoRI and a single 6 Kb DNA fragment that contained exon 1 was identified by Southern blotting using a murine TGH exon 1-specific probe: ATGCGCCTCTACCCTCTGATATG. This fragment was subcloned and sequenced by gene walking using overlapping primers to determine sequences upstream of the transcriptional start site. The sequence of the murine TGH promoter was confirmed by sequencing both strands of the DNA. A genomic fragment encoding the murine TGH promoter region spanning -542 and +112 was cloned into the T/A cloning site of pCR2.1 TOPO (Invitrogen) according to the manufacturer s instructions to create pCR (-542/+112). The promoter region was excised from pCR 2.1 TOPO by restriction digestion with KpnI and XbaI. The insert was purified from an agarose gel (Qiagen gel elution kit) and directionally ligated into pCI (Promega) that had been subjected to the same restriction digestion and gel purification. The cloned fragment was released from pCI by restriction digestion with KpnI and SmaI, gel purified, then directionally inserted into the luciferase reporter vector, pGL 3 Basic (Promega) that had also been digested by KpnI and SmaI and gel purified to generate -542Luc. Luciferase reporter plasmids containing serial deletions at the 5 -end of the cloned promoter fragment were generated by standard PCR methods using -542Luc as template and and TGGTCCACAACAGA (-10Luc). In each case, the sequence of the forward primer started with CGCGGTACC (KpnI site in bold). Each of the PCR products was directionally cloned into pGL 3 Basic following restriction digestion of each with KpnI and
SmaI.
Vectors enabling expression of recombinant Sp proteins were obtained from Dr. R.
Tjian (pPacSp1 and pPac0) (14) and Dr. J. Noti (pPacSp3) (15) . The plasmid enabling expression of green fluorescent protein (GFP) in insect cells [copia (XhoI)-eGFP] was kindly provided by Dr. John F. Elliott (University of Alberta).
The cDNA for full-length Th1 (16) was obtained by RT-PCR. Briefly, total RNA was obtained from hearts isolated from 1 day-old mice (as described below for liver) and reverse transcribed with Superscipt II reverse transcriptase (Gibco, BRL) and oligo dT 15 antisense primer. Primers used in subsequent PCR were 5 -ATGAACCTCGTGGGCAGCTAC-3 and 5 -TCACTGGTTTAGCTCCAGCGCCCA-3 .
The PCR (650 bp) product was cloned into the T/A cloning site of pCR2.1 TOPO. Th1
and GFP were excised from PCR2.1 TOPO and copia (XhoI)-eGFP respectively using
XhoI and BamHI and the ThI cDNA fragment was directionally ligated downstream of the copia promoter in place of GFP to generate a Th1 expression plasmid, copia-Th1.
Copia(XhoI) was generated by blunt-end self-ligation after excision of GFP with XhoI Complimentary oligonucleotides (10 nmol of each) were heated at 70…C in 100 l annealing buffer (10 mM Tris-HCl (pH 7.5) containing 100 mM NaCl and 1 mM EDTA).
After 10 min, annealing reactions were slowly cooled to room temperature and 5 pmole of double-stranded oligonucleotide was 5'-end labeled using T4 kinase (BoehringerManheim) and [γ- 
RESULTS

Postnatal expression of TGH in murine liver.
Immunoblot analysis of proteins from livers of mice of various ages demonstrates that TGH protein levels increase dramatically between 20 and 27 days after birth (Fig. 1A ).
TGH mRNA expression in these livers was evaluated by Northern blot hybridization of total RNA with a murine TGH-specific oligonucleotide as probe (Fig. 1B) . TGH mRNA was detected as early as 1 day after birth with maximum expression at 27 days.
TGH transcription was detected with a modified nuclear run-on assay based on RT-PCR (Fig. 1C) . Amplicons for both TGH and G3PDH were generated by RT-PCR of RNA obtained from isolated nuclei in which nuclear transcription proceeded in the absence of exogenously supplied rNTPs. Due to the method of isolation of the nuclei ,it is unlikely that either amplicon represents cytoplasmic RNA contamination. Namely, lysing the cells in an iso-osmotic solution followed by purification of nuclei by sedimentation through a dense solution of sucrose (2M). It is also unlikely that amplification occurred from genomic DNA contamination or immature, unprocessed hnRNA since the PCR primers were designed so that they spanned four introns of the murine TGH gene (13) . The only amplicons detected were those of the expected sizes based on completely spliced cDNA. Indeed, intact splicing machinery can be recovered from nuclei prepared with techniques similar to those employed here (20) . Therefore mature transcripts for both TGH and G3PDH are present in the nucleus in low abundance, and are available to act as functional templates for RT-PCR. In livers from 7-day old mice, no TGH transcription was observed ( Fig. 1C ; + rNTP) above that for transcripts formed in the nuclei prior to nuclear isolation or with endogenous NTPs ( Fig.   1C ; -rNTP). In liver from 27-day old mice, TGH transcripts were much more readily detected when isolated nuclei were supplied exogenous rNTPs. All PCR reactions were terminated while products in the + rNTP reactions were still accumulating. These data suggest that the lower levels of cytosolic TGH mRNA (Fig. 1B ) seen in livers of 7-day old mice might be due to a lower level of transcriptional activity from the TGH gene.
While TGH protein and mRNA expression appear to be temporally spaced, indicating regulation at a post-transcriptional level, the nuclear run-on assay presented here indicates that in the liver, postnatal expression of TGH mRNA is regulated at the level of transcription.
Functional assays of murine TGH promoter activity in primary hepatocytes.
To investigate the transcriptional regulation of the murine TGH gene, a 6 kb DNA fragment derived from a BAC clone, previously demonstrated to contain the entire murine TGH gene (13), was sequenced. This DNA fragment contains exon 1, most of intron 1 and extends 3 kb upstream of the transcription start site and presumably contains the promoter. Fig. 2 shows 542 bp of the 5 sequence flanking exon 1. This sequence is 59% identical to the rat (4), and 46% identical to the previously cloned human (22) promoter. No TATA box was found to precede the transcriptional start site.
Potential binding sites for transcription factors were identified by searching the TRANSFAC database with the murine sequence using the Matinspector program (23).
These sites include three Sp1 binding sites, a NF-1 and two SRE-like sequences.
Interestingly, several of these binding sites are also present in the human and rat promoter sequences suggesting that we have cloned a functional promoter with evolutionarily conserved transcriptional regulatory patterns. Previous evidence for sterol regulation of TGH transcription in the rat has been reported (24, 25) , suggesting that the SRE-like elements are functional. We tested whether or not the cloned The construct with the largest 5 -extension was -542Luc followed by -313Luc.
Transient transfection into primary murine hepatocytes revealed a reproducible reduction of luciferase activity (~50%) upon deletion of the sequence spanning -154 to -117 ( 
Interaction of hepatic nuclear proteins with the murine TGH promoter.
A genomic fragment containing the 5 proximal region of the murine TGH gene (-542 to +112 of exon 1) was cut by restriction enzyme digestion to yield three smaller nonoverlapping fragments designated as the distal (-542 to -371), medial (-370 to -65) and proximal (-64 to +112) promoter regions. Each of these promoter regions was evaluated for their ability to bind proteins from nuclear extracts prepared from 7-and 27-day old mice in an EMSA (Fig. 4) . The medial promoter region exhibited enhanced protein binding with nuclear extracts prepared from 27-day old compared to 7-day old murine liver yielding three major differentially migrating protein-DNA complexes, C1, C2, and C3. Similar migrating complexes with the medial promoter region and nuclear extract from 7 day-old mice was also visible, albeit with considerably longer exposure times or with increased nuclear protein in the binding assay (not shown). While longer exposure times, or increased nuclear protein in the binding assay, also revealed weak protein-DNA complexes with distal and proximal promoter regions (not shown), identical migration profiles were observed with nuclear extracts from 7-and 27-day old murine livers for each of these regions.
DNase I footprinting of the medial promoter region of the murine TGH gene.
To identify the cis-elements within the medial promoter region that bind hepatic nuclear proteins, the medial promoter region was subjected to DNase I footprint analysis ( complexes. Antibodies against Sp2 did not alter the mobility or formation of any of the three complexes. Sp4 expression in the mouse is limited to the brain (27) and, therefore, is not a candidate protein for binding to the murine TGH promoter in the liver.
It is likely that C1, C2 and C3 complexes arise from protein binding at sites A and B since each of these sites was protected from DNase I digestion by binding to protein (Fig. 5) . In an attempt to assign the cis-element(s) responsible for protein binding in each of the 3 complexes, double stranded oligonucleotides corresponding to sites A and B were synthesized and evaluated in EMSAs for their abilities to compete with the medial fragment for protein binding (Fig. 7A) Binding of sites A and B to nuclear proteins from murine liver was examined directly.
As shown in A double stranded oligonucleotide corresponding to site B did not bind nuclear protein (Fig 7B) . This finding is consistent with the observation that a 50-fold molar excess of unlabeled site B oligonucleotide failed to compete with the medial fragment of the TGH promoter for binding nuclear protein (Fig 7A) . Protection of site B is likely the consequence of direct protein binding since binding of nuclear protein to site A yields differentially migrating complexes that account for two out of the three protein-DNA complexes seen with the medial promoter. However, the possibility that DNase I protection of site B resulted from altered secondary structure of DNA induced by protein binding at the adjacent site A cannot be discounted.
Super-shift assays shown above demonstrate that both Sp1 and Sp3 nuclear proteins are involved in binding to the medial fragment of the murine TGH promoter (Fig 6) .
Similar super-shift assays were performed to demonstrate specific interaction with site A (Fig. 7C) . Addition of an antibody specific for Sp1 in an EMSA reaction with 32 P-labeled site A double stranded oligonucleotide and nuclear extract from 27-day old murine liver super-shifted only a fraction of the slower migrating complex (s). However, this complex was completely super-shifted by including 10-fold more anti Sp1 into the super-shift assay (not shown). Addition of an antibody specific for Sp3 super-shifted the faster migrating complex (f). Identical super-shift profiles were obtained with labeled Sp consensus oligonucleotides (not shown), consistent with the band shifts observed by direct Sp1 and Sp3 binding in other studies (26) . Taken together, these data suggest that both Sp1 and Sp3 are capable of binding to the site A element.
Immunoblot analysis of candidate transcription factors that bind to site A and site B of the murine TGH promoter.
One mechanism that might confer increased binding of nuclear transcription factors to site A of the murine TGH promoter at the time of weaning is increased hepatic expression of Sp1 and/or Sp3. We examined the levels of Sp1 and Sp3 protein by immunoblot analysis of nuclear extracts isolated from the livers of 7-and 27-day old mice. As shown in Fig. 8A , low molecular weight proteins were detected with anti-Sp1 antibody in both nuclear extracts. The amount of proteins that specifically cross-reacted with the anti-Sp antibodies was diminished when a peptide against which the antibody was raised was included in the incubation. The proteolysis of Sp1 appeared to be specific since the same nuclear extracts contained immuno-reactive Sp3 having only those molecular weights that would be expected to arise from alternate translational start sites. Interestingly, we observed proteolysis of Sp1, but not Sp3, in nuclear extracts obtained from brain, heart, kidney, and spleen (not shown). Nuclear extracts from livers of 7-and 27-day-old mice contained full-length Sp1 and smaller polypeptide bands with similar profiles and abundance. The levels of Sp3 were also similar in both nuclear extracts. The differences between the levels of Sp1 and Sp3 in day 7 and day 27 hepatic nuclear extracts were not an artifact of the nuclear extract preparation since the levels of the nuclear protein YY1, a ubiquitously expressed transcription factor that interacts with a number of key regulatory proteins (e.g. TBP, TFIIB, TAFII55, Sp1, and E1A) were not affected (29) . Therefore, it is not likely that enhanced binding of these two factors at day 27 is due to alteration in the abundance of Sp1 and Sp3.
Altered levels of phosphorylation of Sp1 result in changed DNA binding activity (30) (31) (32) (33) (34) . Since the levels of Sp1 and Sp3 in the liver were found to be similar at days 7 and 27, we considered the possibility that phosphorylation modulates binding of these partners with E proteins, and the heterodimers bind avidly to consensus (CANNTG) E box motifs that are functionally important elements in the upstream regulatory sequences of many muscle-specific terminal differentiation genes. Th1 was identified as a member of a family of bHLH transcription factors using a modified two-hybrid screen of a murine embryo cDNA library with the Drosophila E protein daughterless, a Drosophila counterpart of mammalian E proteins with specificity very similar to that of E47 (16) . Interestingly, like TGH, Th1 has a developmentally regulated expression pattern that is both stage-and tissue-specific; Th1 mRNA is expressed in the heart and certain neural crest derivatives during embryogenesis and in adult tissue expression is specific to gut and liver (16) . We hypothesized that during the suckling period a lack of E47 and Th1 might account for the decreased binding of nuclear factors to the B site of the TGH promoter and perhaps for the decreased expression of TGH.
As shown in Fig. 8B , E47 is increased in hepatic nuclear extracts derived from 27-day old mice. This increase is not due to the amount of protein loaded since the nuclear levels of YY1 were similar at day 7 and day 27. However, we could not demonstrate an interaction of E47 with the medial promoter by immuno-depletion of nuclear extracts or Sp1-stimulated promoter activity (p<0.005) and positively cooperated with Sp3 to transactivate the promoter above basal activity, albeit modestly (p<0.05) (Fig. 9) .
DISCUSSION
Enhanced interaction of hepatic nuclear proteins from weaned mice with a putative Sp binding site and a degenerate E box motif within the murine TGH proximal promoter.
Marked changes in energy metabolism occur during the transition from fetal to postnatal life and throughout the weaning period. The lipoprotein profile of rats is not completely developed until about 4 weeks after birth, corresponding to the onset of weaning (35) . In addition, rat hepatocytes from fetal and suckling rats secrete substantially lower quantitites of TG and apoB than do hepatocytes from adult rats (36) .
In this study we have demonstrated that TGH mRNA expression is induced in murine liver at the time of weaning (see Fig. 1B ). Nuclear run-on analysis (Fig. 1C) revealed that this up-regulation occurs mainly at the level of transcription. Since apoB mRNA is as abundant in 18-day fetal liver as at any subsequent period of hepatic development (37) we postulated that the developmental increase in TGH expression may be a necessary event in the ontogeny of VLDL assembly/secretion. Hence, we investigated the regulation of TGH expression by analyzing cis-regulatory elements in the TGH promoter and their corresponding transcription factors. These analyses revealed the formation of three specific complexes with a fragment (-370 to -65) of the TGH promoter that were enhanced in nuclear extracts prepared from murine adult liver. DNase I footprinting experiments localized these complexes to two adjacent, yet distinct, ciselements; a putative Sp binding site and a site containing a degenerate E box with putative half sites for E47 and ThI.
Sp1 and Sp3 interact with the murine TGH proximal promoter.
The TGH proximal promoter lacks a TATA motif. In the absence of a TATA box, mechanisms other than direct recruitment of TATA-binding proteins have been implicated in initiating formation of the basal transcription complex. In general, GC-rich promoters are usually considered to be a target for regulation by zinc finger transcription factors, and TATA-less promoters have been shown to be particularly sensitive to regulation by the Sp family of proteins (38) (39) (40) . Sp1, originally identified as a cellular transcription factor necessary for SV40 gene expression, is a ubiquitous nuclear protein that activates the transcription of a wide variety of cell-type specific genes, including the myeloid specific integrin gene CD11β(41), the monocytic specific gene CD14 (42), the liver specific gene encodingα1 acid glycoprotein (43) , and the α2 integrin gene (44) . and C3 complexes with the medial fragment of the TGH promoter.
Sp1 is a potent activator of the murine TGH promoter in SL2 cells.
In (51) and we show by immunoblot analysis that these variants are present in the liver nuclear extracts used. The involvement of any two of these Sp3 variants with a protein(s) that interacts at site B could give rise to the two differentially migrating protein-DNA complexes, namely C1 and C3.
Th1 modulates Sp-induced TGH promoter activity in SL2 cells.
Computer assisted analysis of site B indicates that this site contains a degenerate E box with putative half sites for E47 and Th1 transcription factors. While the expression Liver nuclear extracts were prepared from 7-and 27-day old mice (d7 and d27, respectively) and used in binding assays with each of 3 32 P-labeled promoter fragments:
distal (-542/-371), medial (-370/-68), and proximal (-67/+112). Protein-DNA complexes were resolved on 3.5% non-denaturing PAGE with Tris-borate-EDTA buffer and were detected by auto-radiography. These results are representative of 5 independent experiments, each using freshly isolated nuclear extracts. Hepatic nuclear extracts were prepared from 7-and 27-day old mice (Day 7 and Day 27, respectively) and used in binding assays with the 32 P-labeled medial (-370/-68)
promoter fragment with (+) or without (-) antibodies against Sp1 (Anti-Sp1), Sp2 (AntiSp2) or Sp3 (Anti-Sp3). Protein-DNA complexes and super-shifted complexes were resolved on 3.5% non-denaturing PAGE with Tris-borate-EDTA buffer and were detected by auto-radiography. Three differentially migrating complexes, C1, C2 and C3, are indicated by arrowheads. These results are representative of 5 independent experiments, each using freshly isolated nuclear extracts. by guest on September 1, 2017
